Updates on Managing Type 2 Diabetes Mellitus with Natural Products: Towards Antidiabetic Drug Development

被引:67
作者
Alam, Fahmida [1 ]
Islam, Md. Asiful [1 ]
Kamal, Mohammad Amjad [2 ,3 ,4 ]
Gan, Siew Hua [1 ]
机构
[1] Univ Sains Malaysia, Sch Med Sci, Human Genome Ctr, Kubang Kerian 16150, Kelantan, Malaysia
[2] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21589, Saudi Arabia
[3] Enzymoics, 7 Peterlee Pl, Hebersham, NSW 2770, Australia
[4] Novel Global Community Educ Fdn, 7 Peterlee Pl, Hebersham, NSW 2770, Australia
关键词
Type 2 diabetes mellitus; natural products; in vivo; in vitro; antidiabetic drugs; synergistic interaction; drug development; BLOOD-GLUCOSE LEVELS; IMPROVES INSULIN-RESISTANCE; BETA-CELL FUNCTION; ALPHA-GLUCOSIDASE; IN-VITRO; ZINGIBER-OFFICINALE; INHIBITORY-ACTIVITY; OXIDATIVE STRESS; BROCCOLI SPROUTS; WINE CONSUMPTION;
D O I
10.2174/0929867323666160813222436
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Over the years, natural products have shown success as antidiabetics in in vitro, in vivo studies and clinical trials. Because natural product-derived drugs are more affordable and effective with fewer side-effects compared to conventional therapies, pharmaceutical research is increasingly leaning towards the discovery of new antidiabetic drugs from natural products targeting pathways or components associated with type 2 diabetes mellitus (T2DM) pathophysiology. However, the drug discovery process is very lengthy and costly with significant challenges. Therefore, various techniques are currently being developed for the pre-clinical research phase of drug discovery with the aim of drug development with less time and efforts from natural products. In this review, we have provided an update on natural products including fruits, vegetables, spices, nuts, beverages and mushrooms with potential antidiabetic activities from in vivo, in vitro and clinical studies. Synergistic interactions between natural products and antidiabetic drugs, and potential antidiabetic active compounds from natural products are also documented to pave the way for combination treatment and new drug discovery, respectively. Additionally, a brief idea of the drug discovery process along with the challenges that arise during drug development from natural products and the methods to conquer those challenges are discussed to create a more convenient future drug discovery process.
引用
收藏
页码:5395 / 5431
页数:37
相关论文
共 199 条
[1]  
Acharya Khushali G, 2013, J Basic Clin Pharm, V4, P82, DOI 10.4103/0976-0105.121653
[2]   Inhibition of key enzymes linked to type 2 diabetes and sodium nitroprusside-induced lipid peroxidation in rat pancreas by water extractable phytochemicals from some tropical spices [J].
Adefegha, Stephen Adeniyi ;
Oboh, Ganiyu .
PHARMACEUTICAL BIOLOGY, 2012, 50 (07) :857-865
[3]   Cyanidin-3-rutinoside alleviates postprandial hyperglycemia and its synergism with acarbose by inhibition of intestinal α-glucosidase [J].
Adisakwattana, Sirichai ;
Yibchok-Anun, Sirintorn ;
Charoenlertkul, Piyawan ;
Wongsasiripat, Natthakarn .
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2011, 49 (01) :36-41
[4]  
Adisakwattana S, 2009, J ENZYM INHIB MED CH, V24, P65, DOI [10.1080/14756360801906947, 10.1080/14756360801906947 ]
[5]  
Ahmad M. F., 2015, Journal of Chinese Pharmaceutical Sciences, V24, P156
[6]   In Vitro Inhibitory Effects of Cyandin-3-rutinoside on Pancreatic α-Amylase and Its Combined Effect with Acarbose [J].
Akkarachiyasit, Sarinya ;
Yibchok-Anun, Sirintorn ;
Wacharasindhu, Sumrit ;
Adisakwattana, Sirichai .
MOLECULES, 2011, 16 (03) :2075-2083
[7]   Inhibitory Activities of Cyanidin and Its Glycosides and Synergistic Effect with Acarbose against Intestinal α-Glucosidase and Pancreatic α-Amylase [J].
Akkarachiyasit, Sarinya ;
Charoenlertkul, Piyawan ;
Yibchok-anun, Sirintorn ;
Adisakwattana, Sirichai .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2010, 11 (09) :3387-3396
[8]   Metabolic Control of Type 2 Diabetes by Targeting the GLUT4 Glucose Transporter: Intervention Approaches [J].
Alam, Fahmida ;
Islam, Md. Asiful ;
Khalil, Md. Ibrahim ;
Gan, Siew Hua .
CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (20) :3034-3049
[9]   Economic Costs of Diabetes in the U.S. in 2012 [J].
Yang W. ;
Dall T.M. ;
Halder P. ;
Gallo P. ;
Kowal S.L. ;
Hogan P.F. ;
Petersen M. .
DIABETES CARE, 2013, 36 (04) :1033-1046
[10]  
[Anonymous], PHARM ONLINE